Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find innovative ways to earn while managing debt. These strategies can help you achieve financial stability.
27,826 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A potential U.S. strike on Iran could squeeze global oil supplies and push prices higher, forcing households and inve...
What to expect from Kodiak’s 2025 earnings? This guide breaks down revenue drivers, margins, and realistic scenarios ...
Markets are unsettled, but long-term investors can find value. This guide highlights three AI leaders that are curren...
The mood around U.S. housing is shifting. Prices, rents, and mortgage costs are moving in ways that could change how ...
As earnings season unfolds, Innventure (INV) investors want clarity on growth, margins, and guidance. This article br...
A shrinking market breadth exposes investors to a narrow rally as earnings revisions pile up around AI-related names....
SpaceX IPO chatter has investors buzzing, but the real story lies in cash flow, contracts, and risk. This guide break...
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...
DTE Energy is nearing its 52-week high after a robust first half of 2026, supported by utility earnings and a rising ...
Finance Of America has closed an all-cash acquisition of Onity’s reverse mortgage servicing rights, adding roughly 20...
In 2025, the U.S. minted 441,000 new millionaires as the median American wealth contracted, underscoring a split econ...